Arthur D. Little
Emmanuelle Quiles serves as the Worldwide Vice President of Cardiovascular & Metabolism and Pulmonary Hypertension at Johnson & Johnson Innovative Medicine, and holds the position of Managing Director and Vice President at Arthur D. Little. Additionally, Emmanuelle Quiles is a member of the Blue Shift Institute Scientific Advisory Board and has served as Chairwoman of the Innovation and Industry Strategic Committee at Genopole. Emmanuelle Quiles is also a Board Member at Business France and the Founder, Owner, and Managing Director of Harmonium Pharma. Emmanuelle Quiles earned an Ingénieur en Biotechnologie and a DEA in Biologie Moléculaire et Cellulaire from ESBS between 1987 and 1990, and is currently pursuing a degree in Leading Change and Organizational Renewal at Stanford University Graduate School of Business.
This person is not in any teams
This person is not in any offices
Arthur D. Little
26 followers
Arthur D. Little is an international management consulting firm originally headquartered in Boston, Massachusetts, United States, and formally incorporated by that name in 1909 by Arthur Dehon Little, an MIT chemist who had discovered acetate.